| 0 (0%) | 11-30 07:31 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.84 |
1-year : | 2.15 |
| Resists | First : | 1.58 |
Second : | 1.84 |
| Pivot price | 1.33  |
|||
| Supports | First : | 1.24 |
Second : | 1.03 |
| MAs | MA(5) : | 1.23 |
MA(20) : | 1.36 |
| MA(100) : | 1.85 |
MA(250) : | 31.8 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 47.4 |
D(3) : | 35.6 |
| RSI | RSI(14): 49.9 |
|||
| 52-week | High : | 298 | Low : | 1.03 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ APVO ] has closed below upper band by 42.2%. Bollinger Bands are 6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.29 - 1.29 | 1.29 - 1.3 |
| Low: | 1.19 - 1.2 | 1.2 - 1.2 |
| Close: | 1.27 - 1.28 | 1.28 - 1.29 |
Thu, 27 Nov 2025
Aptevo Therapeutics Inc. (APVO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Wed, 19 Nov 2025
Aptevo Therapeutics (APVO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Nasdaq
Wed, 12 Nov 2025
Insider Purchase: Director at $APVO Buys 13,513 Shares | APVO Stock News - Quiver Quantitative
Thu, 06 Nov 2025
Aptevo (NASDAQ: APVO) extends cash runway to 4Q26 on $18.7M raise and business update - Stock Titan
Wed, 08 Oct 2025
Interim RAINIER results: Aptevo to present Phase 1b/2 AML data at ASH, SITC, BIO-Europe and ROTH this fall - Stock Titan
Tue, 07 Oct 2025
APVO Stock Soars After Impressive Trial Results - StocksToTrade
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 17 (M) |
| Held by Insiders | 1.531e+007 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 1,390 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 1 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -79.2 % |
| Return on Equity (ttm) | -242.8 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 241259 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -1.85105e+007 |
| Qtrly Earnings Growth | 950.7 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -26 (M) |
| PE Ratio | 1.37 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 1.56 |
| Dividend | 0 |
| Forward Dividend | 501240 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|